INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 04, 2015 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 92,947 |
| Nov 04, 2015 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 1,203 |
| Nov 03, 2015 |
Director, President Regeneron Laboratori
Trans History: 617
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Nov 03, 2015 |
Director, President Regeneron Laboratori
Trans History: 617
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 569,588 |
| Sep 22, 2015 |
Director
Trans History: 466
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 18,349 |
| Sep 03, 2015 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,681 |
| Sep 02, 2015 |
SVP General Counsel and Secret
Trans History: 181
|
SVP General Counsel and Secret | Form 4 | Other acquisition or disposition | -- | -- | 120 |
| Aug 17, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 12,890 |
| Aug 17, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 1,652 |
| Aug 07, 2015 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Other acquisition or disposition | -- | -- | 1,651 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.